eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients

April 23, 2023 updated by: National Taiwan University Hospital

The Effectiveness of eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients:a Randomized Controlled Trial.

The goal of this randomized controlled trial is to compare the effect of eHealth-based cardiac rehabilitation with the effect of usual care on exercise capacity and qualify of life in patients after myocardial infarction.

Study Overview

Status

Recruiting

Detailed Description

Cardiac rehabilitation can improve exercise capacity, life of quality, readmission rate and mortality rate for patients after myocardial infarction. International guidelines list cardiac rehabilitation after myocardial infarction as class IA recommendation. However, low participation rate of cardiac rehabilitation due to barriers such as lacking of time, transport or affordability issues is an unsolved problem worldwide.

eHealth, consisting of telemedicine, mobile health and personalized care using wearable devices has the potential to remove the barriers and become an effective model to deliver cardiac rehabilitation. Thus, we design a randomized controlled trial to compare the effect of a case manager-led eHealth-based cardiac rehabilitation program with usual care on the compliance, physical activity, quality of life, and cardiorespiratory fitness in patients after myocardial infarction.

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Hung-Jui Chuang, MD
  • Phone Number: 67034 00886-2-23123456
  • Email: 103311@ntuh.gov.tw

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

  1. ≥ 20 years of age.
  2. Within 6 months after the onset of acute myocardial infarction.
  3. At lowest to moderate risk according to the guideline from American Association of Cardiovascular and Pulmonary Rehabilitation.
  4. Unable or refused to attend center-based cardiac rehabilitation.

Exclusion criteria:

  1. Unable to walk independently or use a stationary bike.
  2. Unable to follow verbal command.
  3. Not having a smartphone which can get on the internet.
  4. Having contraindications for exercise according to American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.
  5. Unable to provide informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: eHealth-based cardiac rehabilitation
Participants receive a 12-wk case manager-led eHealth-based cardiac rehabilitation program with follow-up at 12 week, 6 months and 12 months.

The 12-wk case manager-led eHCR program includes:

  1. Individualized exercise prescription according to the results of cardiopulmonary exercise test.
  2. At least one session of in-person physical therapy to familiarize participants with the process of exercise training before the initiation of telerehabilitation.
  3. Telerehabilitation: a 30-minute moderate aerobic exercise training with remote monitoring and instruction using video conferencing. (Frequency: twice per week in the first 4 weeks, once per week in the 5th-8th week, once every 2 weeks in the 9th-12th week)
  4. Additional self-exercise to achieve the target volume of 150-minute moderate aerobic exercise and 2 sessions of resistance training per week.
  5. Patient education for secondary prevention delivered regularly via a communication app on the smartphone.
  6. Weekly follow-up call from a case manager via phone call or communication app.
Other Names:
  • eHCR
No Intervention: Usual care
Participants receive usual care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of peak oxygen uptake
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
at baseline, 12 weeks(post-intervention), and 12 months.
Change of ventilatory anaerobic threshold
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
Ventilatory anaerobic threshold will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
at baseline, 12 weeks(post-intervention), and 12 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to prescribed exercise
Time Frame: at 12 weeks(post-intervention) and 12 months.
The degree of completion of prescribed exercise will be assessed at 12 weeks and 12 months.
at 12 weeks(post-intervention) and 12 months.
Evaluation of Quality of life
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in 36-Item Short Form Survey(SF-36).
at baseline, 12 weeks(post-intervention), and 12 months.
Depression
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in Patient Health Questionnaire (PHQ-9). The PHQ-9 score ranges from 0-27. Higher scores indicate worsen symptoms.
at baseline, 12 weeks(post-intervention), and 12 months.
Anxiety
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7). The GAD-7 score ranges 0-21. Higher scores indicate worsen symptoms.
at baseline, 12 weeks(post-intervention), and 12 months.
Evaluation of physical activity
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
The investigators will assess the change in physical activity using Long form International Physical Activity Questionnaire(IPAQ) Taiwan version.
at baseline, 12 weeks(post-intervention), and 12 months.
Evaluation of grip strength
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees.
at baseline, 12 weeks(post-intervention), and 12 months.
Evaluation of isometric knee extension strength
Time Frame: at baseline, 12 weeks(post-intervention), and 12 months.
The isometric knee extension strength will be measured using a dynamometer with participants seated and knee flexed at 90 degrees.
at baseline, 12 weeks(post-intervention), and 12 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hung-Jui Chuang, MD, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2023

Primary Completion (Anticipated)

December 1, 2024

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

January 3, 2023

First Submitted That Met QC Criteria

January 9, 2023

First Posted (Actual)

January 19, 2023

Study Record Updates

Last Update Posted (Actual)

April 25, 2023

Last Update Submitted That Met QC Criteria

April 23, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Clinical Trials on eHealth-based cardiac rehabilitation

3
Subscribe